Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Novaferon for COVID-19 Treatment Trial (NCTT-005)

  • Read more about Novaferon for COVID-19 Treatment Trial (NCTT-005)

Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen

  • Read more about Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen

Tolerability and Efficacy of RJX in Patients With COVID-19

  • Read more about Tolerability and Efficacy of RJX in Patients With COVID-19

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

  • Read more about Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19

  • Read more about To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19

NoRCoRP Assessment Clinic

  • Read more about NoRCoRP Assessment Clinic

HEALthy Brain and Child Development Study - COVID-19 Supplement

  • Read more about HEALthy Brain and Child Development Study - COVID-19 Supplement

Vaccination Against COVID-19 in Cancer

  • Read more about Vaccination Against COVID-19 in Cancer

The Nanowear Wearable Covid-19 Observational and Analysis Trend

  • Read more about The Nanowear Wearable Covid-19 Observational and Analysis Trend

Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care

  • Read more about Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 235
  • Page 236
  • Page 237
  • Page 238
  • Current page 239
  • Page 240
  • Page 241
  • Page 242
  • Page 243
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA